Health News

No matter how sophisticated modern medicine becomes, common ailments like fungal infections can outrun the best of the world’s antibiotics.

Read more

Filed under: Pharmacy News
Tags: Drug, medicine, Pharmacy

Related posts

• Æterna Zentaris Zentaris requests EMA Scientific Advice for Phase 3 program with perifosine (0)
  Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has requested Scientific Advice from the European Medicines Agency (EMA) to assure the acceptability of the recently initiated Phase 3 programs for the development of its lead anticancer compound, perifosine, in its two lead indications, multiple myeloma [...]
  
  
• Zogenix, Desitin receive MAA approval for SUMAVEL DosePro in Germany and the UK (0)
  Aradigm Corporation today announced that Zogenix, Inc. and Desitin Pharmaceuticals GmbH were granted approval of the Marketing Authorization Application for SUMAVEL® DosePro™ (sumatriptan injection) needle-free delivery system for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache by the Federal Institute for Drugs and Medical Devices of [...]
  
  
• Zocor, Crestor drugs may cause serious muscle and kidney problems (0)
  Crestor and Zocor are widely-used prescription strength drugs designed to lower "bad cholesterol". Both drugs are classified as "statins", medicine which lowers blood cholesterol levels by inhibiting HMG-CoA reductase. Read more [tags] Pharmacy News [/tags]
  
  
• Zileuton can help reduce amyloid plaque formation and Alzheimer’s development (0)
  A drug used to treat asthma has been shown to help reduce the formation of amyloid beta, a peptide in the brain that is implicated in the development of Alzheimer's disease, according to researchers at Temple University's School of Medicine. Read more [tags] Pharmacy News [/tags]
  
  
• Yale University: Gabapentin clinical study on epilepsy may have been a ’seeding trial’ (0)
  Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a "seeding trial" used by a pharmaceutical company to promote the drug and increase prescriptions, according to a report in the June issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Read more [tags] Pharmacy News [...]